GLP-1 weight loss drugs could increase risk of osteoporosis and gout, new research finds Bookmark CommentsGo to comments Taking popular GLP-1 class weight loss drugs like Ozempic and Wegovy could be linked to a higher risk of developing osteoporosis, gout and a condition that causes severe bone softening compared to people who dont use the medications, researchers said Monday
[9] [11] Their habitat has also been impacted by human interaction via the development of roads, buildings, and other infrastructure and agriculture which involves the destruction of their habitat
To view or add a comment, sign in For colleagues interested in #tuberculosis treatment and #CNS #pharmacology, Im happy to share that our manuscript, Central nervous system antituberculosis drug exposures in a rabbit model of tuberculous meningitis, has now been published in Antimicrobial Agents and Chemotherapy
Arch Dis Child Fetal Neonatal Ed (2014) 99(2):F1105
If your priority is the strongest available evidence and a clear regulatory paper trail, Aqualyx is the standard option
We start in the periphery with vagal, intestinofugal, and spinal sensory nerves and then progress through the brainstem up to the hypothalamus and finish at non-canonical brain feeding centers such as the zona incerta and lateral septum
